Slovak Actress Zuzana Mauréry Stops Mounjaro Due to Throat Side Effect Threatening Singing Career
Slovak actress Zuzana Mauréry has stopped taking the weight-loss drug Mounjaro after a throat side effect threatened her singing career, speaking openly about a lifelong eating disorder she says went undiagnosed for decades, according to Europesays.
The 11-kilogram shift came with a trade-off, and Diva.sk reported she is taking a break from the drug even though she expects to return to it.
Mauréry made her admission at the premiere of the film Niečo ako rodina, where she appeared in dark, fitted clothing and acknowledged the change plainly. “Podstúpila som liečbu Mounjarom,” she told the Czech outlet iDnes.cz, according to Diva.sk, saying she turned to the drug after a long effort to lose weight through other means.
The disclosure matters beyond one premiere. Weight-loss medication use is more widespread than ever, yet as Diva.sk notes, many public figures still refuse to admit to it — some insisting their results come from consistent healthy eating and exercise alone. Mauréry did the opposite, and paired the admission with a diagnosis she had never discussed publicly.
“Mám poruchu príjmu potravy. Vždy som ju mala, ale kedysi sa to nediagnostikovalo,” Mauréry told iDnes.cz. “Vraveli vám, že nemáte pevnú vôľu, aby ste viac cvičili a menej žrali. Ale keď si s tým počas rokov neviete poradiť, aj keď robíte všetko možné…”

The drug worked, then her throat objected
Mounjaro works by activating receptors for the hormones GIP and GLP-1, slowing digestion and dampening appetite. For Mauréry, the promised effect arrived. She has lost 11 kilograms, and described the shift as chemical rather than moral.
“Po Mounjare som zrazu pocítila, aké to je, keď vám chémia ovplyvní mozog a vypne ten neustály chtíč po jedle. V tej chvíli si poviete, aha, tak mne naozaj chemicky niečo v tom tele chýba. Ale, samozrejme, som pod lekárskym dohľadom. Neberiem to na ľahkú váhu,” Mauréry told iDnes.cz.
The problems came alongside the results. “Moje telo nie je s Mounjarom príliš kompatibilné, takže k nemu beriem ešte ďalšie dvoje lieky,” she said, adding that reflux developed and a lump formed in her throat. Because she sings professionally, she had to stop using the drug. She remains on that pause now, though she believes she will go back.
Safety framing around the drug class is not Mauréry’s own speculation. Diva.sk points to the information leaflet for the approved drug from the U.S. Food and Drug Administration, which flags possible elevated risks — for Ozempic, for example, thyroid cancer and pancreatitis.
Her framing of the treatment is medical, not cosmetic. “Ale ten doktor, ktorý ma lieči a robí tomu veľkú osvetu, mi hovorí, že keď má niekto vysoký tlak, berie na to lieky. A ja mám poruchu príjmu potravy, na ktorú treba tiež brať medikamenty,” Mauréry said, crediting the drug with an 11-kilogram loss that she says her body celebrates.
“Je to fakt veľký rozdiel v tej hlave, keď stále nebažíte po jedle a môžete sa venovať iným veciam…” she told iDnes.cz.
Mauréry isn’t the only Slovak voice on the record
Diva.sk names several other Slovak public figures who have admitted to using weight-loss medication. Stylist Lenka Bohunická (Škodová) shared her transformation on social media, echoing the caveat Mauréry offers: the drug on its own is not the answer.
“Verte mi, že to ide ruka v ruke len so správnou životosprávou. Keby som nezmenila stravu a nezačala cvičiť, nebola by som tam kde som. A v tom mi liek pomohol,” Bohunická said.
Diva.sk’s reporting runs the two framings side by side: a doctor friend told Mauréry the side effects were nothing next to the problems visceral fat causes in the body, yet the throat symptoms still forced her off the drug. Both things are true at once — which is roughly where the wider conversation about these medications now sits.
An 11-kilogram loss, a diagnosis decades late and a paused prescription: that, as of Mauréry’s admission at the premiere of the film Niečo ako rodina, is what openness about these drugs looks like.